Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients

European Journal of Cancer

Volumn 45, Issue 13, 2009, Pages 2312-2315

  Fiebrich, Helle Brit ^a   Brouwers, Adrienne H ^a   Koopmans, Klaas Pieter ^a   de Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Carcinoid tumour; Positron emission tomography; Second primary neoplasms

Indexed keywords

6 FLUORODOPA F 18; CATECHOLAMINE; FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CARCINOID; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECOND CANCER;

ADENOCARCINOMA; AGED; CARCINOID TUMOR; DIAGNOSIS, DIFFERENTIAL; DIHYDROXYPHENYLALANINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68749092790     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.037     Document Type: Article

References (19)

1. Gerstle J.T., Kauffman Jr. G.L., and Koltun W.A. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg 180 (1995) 427-432
2. de Groot J.W., Links T.P., Jager P.L., et al. Impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 11 (2004) 786-794
3. De Vries E.F.J., Luurtsema G., Brussermann M., et al. Fully automated synthesis module for the high yield one-pot preparation of 6-[18F]fluoro-l-DOPA. Appl Radiat Isot 51 (1999) 389-394
4. Brown W.D., Oakes T.R., DeJesus O.T., et al. Fluorine-18-fluoro-l-DOPA dosimetry with carbidopa pretreatment. J Nucl Med 39 (1998) 1884-1891
5. Ishikawa T., Dhawan V., Chaly T., et al. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis. J Cereb Blood Flow Metab 16 (1996) 854-863
6. Orlefors H., Sundin A., Lu L., et al. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging 33 (2006) 60-65
7. Habal N., Sims C., and Bilchik A.J. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 75 (2000) 310-316
8. Wood K.A., Hoskin P.J., and Saunders M.I. Positron emission tomography in oncology: a review. Clin Oncol (R Coll Radiol) 19 (2007) 237-255
9. Adams S., Baum R., Rink T., et al. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25 (1998) 79-83
10. Belhocine T., Foidart J., Rigo P., et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun 23 (2002) 727-734
11. Chong S., Lee K.S., Kim B.T., et al. Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications. Am J Roentgenol 188 (2007) 1223-1231
12. Daniels C.E., Lowe V.J., Aubry M.C., et al. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest 131 (2007) 255-260
13. Erasmus J.J., McAdams H.P., Patz Jr. E.F., et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. Am J Roentgenol 170 (1998) 1369-1373
14. Le Rest C., Bomanji J.B., Costa D.C.., et al. Functional imaging of malignant paragangliomas and carcinoid tumours. Eur J Nucl Med 28 (2001) 478-482
15. Kayani I., Bomanji J.B., Groves A., et al. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112 (2008) 2447-2455
16. Koopmans K.P., Neels O.C., Kema I.P., et al. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol 26 (2008) 1489-1495
17. Koopmans K.P., de Vries E.G., Kema I.P., et al. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 7 (2006) 728-734
18. Hoegerle S., Altehoefer C., Ghanem N., et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 220 (2001) 373-380
19. Pasquali C., Rubello D., Sperti C., et al. Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior?. World J Surg 22 (1998) 588-592